FDA notifications. New dosing option approved for Viracept.
D017320:HIV Protease Inhibitors / Q000008:administration & dosage*; D006801:Humans; D019888:Nelfinavir / Q000008:administration & dosage*; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence*
D017320:HIV Protease Inhibitors; D019888:Nelfinavir